CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-22 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Option exercise · Performance Stock Units | −9,191 | 0 | ||
| 2023-05-17 | Trencher Daniel CHIEF STRATEGY OFFICER | Sale 10b5-1 | −1,000 | $23.81 | $24K | 23,520 |
| 2023-05-04 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Sale | −1,699 | $25.64 | $44K | 13,540 |
| 2023-05-03 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Option exercise | +5,616 | 15,239 | ||
| 2023-05-03 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Option exercise · Restricted Stock Units | −5,616 | 5,617 | ||
| 2023-05-02 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Sale | −15,372 | $26.76 | $411K | 25,620 |
| 2023-05-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise | +40,975 | 40,992 | ||
| 2023-05-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −40,975 | 81,952 | ||
| 2023-05-01 | Napolitano Richard J CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +4,444 | 4,444 | ||
| 2023-04-17 | Trencher Daniel SVP CORPORATE STRATEGY | Sale 10b5-1 | −1,000 | $25.30 | $25K | 24,520 |
| 2023-03-17 | Trencher Daniel SVP CORPORATE STRATEGY | Sale | −1,000 | $25.13 | $25K | 25,520 |
| 2023-03-03 | Trencher Daniel SVP CORPORATE STRATEGY | Sale | −1,838 | $25.91 | $48K | 26,520 |
| 2023-03-03 | Trencher Daniel SVP CORPORATE STRATEGY | Grant or award · Restricted Stock Units | +33,482 | 33,482 | ||
| 2023-03-03 | Napolitano Richard J CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +14,126 | 14,126 | ||
| 2023-03-03 | Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH | Grant or award · Restricted Stock Units | +83,705 | 83,705 | ||
| 2023-03-03 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Sale | −22,040 | $25.91 | $571K | 603,434 |
| 2023-03-03 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +186,012 | 186,012 | ||
| 2023-03-03 | Verstraete Stephany CHIEF MARKETING OFFICER | Sale | −2,873 | $25.91 | $74K | 40,417 |
| 2023-03-03 | Verstraete Stephany CHIEF MARKETING OFFICER | Grant or award · Restricted Stock Units | +39,063 | 39,063 | ||
| 2023-03-03 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Sale | −5,096 | $25.91 | $132K | 20,689 |
Page 50 of 74 · 1,476 trades